Literature DB >> 7707918

Computerized consensus diagnosis: a classification strategy for the robust analysis of MR spectra. I. Application to 1H spectra of thyroid neoplasms.

R L Somorjai1, A E Nikulin, N Pizzi, D Jackson, G Scarth, B Dolenko, H Gordon, P Russell, C L Lean, L Delbridge.   

Abstract

We introduce and apply a new classification strategy we call computerized consensus diagnosis (CCD). Its purpose is to provide robust, reliable classification of biomedical data. The strategy involves the cross-validated training of several classifiers of diverse conceptual and methodological origin on the same data, and appropriately combining their outcomes. The strategy is tested on proton magnetic resonance spectra of human thyroid biopsies, which are successfully allocated to normal or carcinoma classes. We used Linear Discriminant Analysis, a Neural Net-based method, and Genetic Programming as independent classifiers on two spectral regions, and chose the median of the six classification outcomes as the consensus. This procedure yielded 100% specificity and 100% sensitivity on the training sets, and 100% specificity and 98% sensitivity on samples of known malignancy in the test sets. We discuss the necessary steps any classification approach must take to guarantee reliability, and stress the importance of fuzziness and undecidability in robust classification.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7707918     DOI: 10.1002/mrm.1910330217

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  12 in total

1.  Prediction of treatment response in head and neck cancer by magnetic resonance spectroscopy.

Authors:  Tedros Bezabeh; Olva Odlum; Richard Nason; Paul Kerr; Donna Sutherland; Rakesh Patel; Ian C P Smith
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

2.  Periodontitis-specific molecular signatures in gingival crevicular fluid.

Authors:  X M Xiang; K Z Liu; A Man; E Ghiabi; A Cholakis; D A Scott
Journal:  J Periodontal Res       Date:  2010-03-09       Impact factor: 4.419

Review 3.  Creating robust, reliable, clinically relevant classifiers from spectroscopic data.

Authors:  R L Somorjai
Journal:  Biophys Rev       Date:  2009-11-25

Review 4.  Deriving biomedical diagnostics from NMR spectroscopic data.

Authors:  Ian C P Smith; Ray L Somorjai
Journal:  Biophys Rev       Date:  2011-03-08

5.  The role of neural networks in improving the accuracy of MR spectroscopy for the diagnosis of head and neck squamous cell carcinoma.

Authors:  R J Gerstle; S R Aylward; S Kromhout-Schiro; S K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

6.  Identification of Enterococcus, Streptococcus, and Staphylococcus by multivariate analysis of proton magnetic resonance spectroscopic data from plate cultures.

Authors:  R Bourne; U Himmelreich; A Sharma; C Mountford; T Sorrell
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

7.  Tobacco-induced alterations to the Fourier-transform infrared spectrum of serum.

Authors:  J T Borden; A Man; D A Scott; K-Z Liu
Journal:  J Mol Med (Berl)       Date:  2003-10-10       Impact factor: 4.599

8.  Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T.

Authors:  Peter Stanwell; Laurence Gluch; David Clark; Boguslaw Tomanek; Luke Baker; Bruno Giuffrè; Cynthia Lean; Peter Malycha; Carolyn Mountford
Journal:  Eur Radiol       Date:  2004-09-03       Impact factor: 5.315

9.  Proteomics, and metabolomics: magnetic resonance spectroscopy for the presurgical screening of thyroid nodules.

Authors:  Michele N Minuto; Laetitia Shintu; Stefano Caldarelli
Journal:  Curr Genomics       Date:  2014-06       Impact factor: 2.236

10.  Statistical classification strategy for proton magnetic resonance spectra of soft tissue sarcoma: an exploratory study with potential clinical utility.

Authors:  Tedros Bezabeh; Samy El-Sayed; Rakesh Patel; Ray L Somorjai; Vivien Bramwell; Rita Kandel; Ian C P Smith
Journal:  Sarcoma       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.